Quick take: Bintai Kinden among top traded

KUALA LUMPUR: Bintai Kinden Corp Bhd was the third most actively traded counter on Bursa Malaysia following news of its collaboration with dialyser manufacturer Scientillence Sdn Bhd.

At 10.15am, the company's share price was up two sen or 3.77% to 55 sen on the back of 31 million shares traded.

Earlier in the day, the stock had risen to a trading high of 56.6 sen apiece amid rapidly rising turnover.

Bintai had said in a filing with Bursa Malaysia yesterday that its healthcare unit was partnering Scientillence to develop and market medical products in the hemodialysis market.

The joint venture would also work towards developing, investing, acquiring or owning dialysis centres and other renal care businesses in Malaysia and Southeast Asia.

Scientillence, owned by the ex-CEO and chairman of hospital group Pantai Holdings Bhd Tan Sri Lim Tong Yong, is the sole manufacturer of dialyser (artificial kidney) in Malaysia as well as Southeast Asia.

The partnership between Bintai Healthcare and Scientillence will facilitate Bintai Group to tap into the hemodialysis market as part of its business strategies to widen its range of products and services including distribution of medical devices and healthcare solutions in Malaysia.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 0
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Business News

Exciting deals at Sunway Theme Parks Mega Roadshow
CPO futures likely to trade in yo-yo mode next week
Maybe Apple’s weakness isn’t just supply chain woes
Good news for the global economy
BP, Chubu Power to study CCS project at Nagoya
Short Position: Private equity exits, Managing cyber threats, Don’t kick the can down the road
Bonds surge as traders call time on hikes
Central banks continue fight against inflation
Defining market manipulation
Lee Chun Fai redesignated as IJM CEO and MD

Others Also Read